MedTrace Logo

The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity

NCT03297801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2024-07-23

No results posted yet for this study

Summary

Prenatal supplementation with fish oil, rich in omega-3 polyunsaturated fatty acids, is widely recommended in Canada. The aim of this observational, prospective cohort study is to determine the effects of maternal fish oil supplements on the development of their infants' gut microbiota and immunity.

Conditions

  • Microbial Colonization
  • Infant Development

Interventions

DIETARY_SUPPLEMENT

Fish oil supplements

Women who chose to supplement with fish oil during gestation or lactation.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Deanna L Gibson, Ph.D. · University of British Columbia

Eligibility

Min Age
5 Days
Max Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-22
Primary Completion
2017-01-31
Completion
2017-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03297801 on ClinicalTrials.gov